Additionally, it addresses the FDA’s communications With all the applicant, the retention of records that help the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer possession of the SE report to a completely new applicant and Digital submission in the SE report